VF
RVMD icon

Virtu Financial’s Revolution Medicines RVMD Stock Holding History

Virtu Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Buy
+2,918
New +$295K 0.01% 839
2025
Q3 		– Sell
-43,005
Closed -$1.58M – 1999
2025
Q2 		$1.58M Buy
+43,005
New +$1.65M 0.08% 220
2025
Q1 		– Sell
-6,224
Closed -$272K – 1943
2024
Q4 		$272K Buy
+6,224
New +$314K 0.01% 747
2023
Q4 		– Sell
-13,457
Closed -$372K – 1942
2023
Q3 		$372K Buy
+13,457
New +$399K 0.04% 424

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Virtu Financial's RVMD Position: Q1 2026 in Review

Virtu Financial opened a new position in Revolution Medicines (RVMD) in Q1 2026: 2,918 shares worth $284K. The stake represents 0.01% of the portfolio and ranks #839 among its holdings. This is a return to the name: Virtu Financial previously reported a position in RVMD as recently as Q2 2025.

Virtu Financial first reported a position in RVMD in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.58M in Q2 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Virtu Financial held 2,918 shares of Revolution Medicines worth $284K as of Q1 2026.
  • Revolution Medicines was a new Virtu Financial position in Q1 2026.
  • Revolution Medicines made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #839 holding.
  • Virtu Financial first reported a position in Revolution Medicines in Q3 2023 and has held it in 4 quarters since.
  • Virtu Financial's Revolution Medicines position peaked at $1.58M in Q2 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.